Acadia Pharmaceuticals | ACAD - ДОЛГ





ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Cytokinetics USD 1.29B 4.48M 2026-03
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Incyte USD 39.43M 982K 2026-03
J&J USD 47.93B 2.14B 2025-12
Moderna USD 1.31B 571M 2025-12
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Pfizer USD 63.73B 231M 2026-03
Prothena USD 9.08M 699K 2025-09
PTC Therapeutics USD 286.94M 2.42B 2026-03
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03